Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Conference, Event

2022 DIA Global Annual Meeting Convenes Top Life Science Leaders to Address Pressing Industry Challenges and Opportunities


DIA, the premier professional global community for healthcare product development, will host its in-person Global Annual Meeting in Chicago on June 19-23. This event marks the first time since 2019 that the association has convened global industry, regulators, academics, and patients together face-to-face with a goal of exploring and discussing some of the life science industry's most pressing challenges and opportunities.

Attendees will benefit from DIA's neutral, transparent platform, which provides an opportunity for top leaders and minds in the clinical trial and drug development fields to co-create, problem-solve and discuss global and regional challenges faced by all stakeholders in the life sciences community.

DIA's Global Annual Meeting 2022 includes over 150 sessions across 13 educational tracks, covering topics such as FDA regulations with insights from FDA officials, navigating global crises, patient-focused drug development, DE&I, real-world data collection and utilization, and more. These sessions, led by global and regional experts from some of the top life science organizations and associations, will inspire a worldwide discussion, representing many multidisciplinary perspectives to achieve actionable, innovative solutions between pharma, regulatory agencies, patients, academia and beyond.

"In the last several years, the life science industry has been front-and-center facing global crises - from the unprecedented COVID-19 pandemic to the crisis in Ukraine. Organizations across the globe have had to adapt, quickly, and as a result our industry will never be the same," said Barbara Lopez Kunz, President and Global Chief Executive of DIA. "This year's Global Annual Meeting is an opportunity for clinical development leaders, experts, researchers and patients to finally reunite for open and honest collaboration that will impact our toughest challenges - both locally and globally."

Highly anticipated sessions at the event include:

Attendees and interested parties can learn more about popular topics that will be covered at DIA's Global Annual Meeting by exploring the searchable event program, and by registering for the event here.

About DIA

DIA (founded as the Drug Information Association) is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers, and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow. As a member-driven, volunteer organization, professionals from 80 countries have affected healthcare outcomes by engaging with DIA through an unparalleled network, educational offerings, and professional development opportunities.

DIA is based in Washington, DC (US) with regional offices representing the Americas (Horsham, PA, US); Europe, the Middle East, and Africa, (Basel, Switzerland); and Asia (Beijing and Shanghai, China; Mumbai, India; and Tokyo, Japan).

Learn more and register for the DIA Global Annual Meeting 2022 at DIAglobal.org/DIA2022. For live updates, search social media with #DIA2022, and connect with DIA on Twitter, LinkedIn, Facebook, and Instagram.


These press releases may also interest you

at 15:22
The founders of Country Roads RV Center are pleased to announce their current sales, promotions and updates for June, 2022.  To learn more about Country Roads and check out their latest news, please...

at 12:01
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Yext, Inc. securities between March 4, 2021 and March 8, 2022, both dates inclusive (the "Class Period") have until August 16, 2022 to seek appointment as...

at 10:20
Chinese President Xi Jinping on Wednesday offered his answers to the questions of the times at a keynote speech in virtual format at the opening ceremony of the BRICS Business Forum in Beijing and called for joint efforts to seek and safeguard peace....

at 10:05
Pfizer Inc. and BioNTech SE today announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine candidates: one monovalent and the other bivalent, a combination of the Pfizer-BioNTech...

at 09:05
Ionis Pharmaceuticals, Inc. , today...

at 06:15
Using Verv, business customers in Europe can open a digital bank account with its unique IBAN ? International Bank Account Number ? for standardised banking services worldwide. This is the international equivalent of Australia's BSB system but on a...



News published on 24 may 2022 at 09:20 and distributed by: